Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2020 Oct 1;29(11):1432–1439. doi: 10.1002/pds.5111

Table 2.

Demographic Characteristics for the VACS Biomarker Cohort, by HIV Status

All PWH HIV-negative Standardized Differences
N 2,389 1,546 843

Mean age (SD) 52 (8.9) 52 (8.2) 54 (9.3) 0.203
Male sex (%) 95 97 90 −0.289
Race/ethnicity (%)
African-American, non-Hispanic 68 69 67 −0.026
 White, non-Hispanic 20 19 21
 Hispanic 8 8 8
 Other/unknown 4 4 4
HCV+ (%) 36 40 28 −0.271
Prevalent Diabetes (%)
 Chart adjudication 22 18 29 0.266
 EMR ICD-9 Code 27 22 37 0.319
 EMR HbA1c ≥6.5% at least once 21 16 28 0.276
 EMR HbA1c ≥6.5% two or more times 17 13 24 0.299
 EMR HbA1c ≥6.5% two or more times within a year 13 10 19 0.273
 EMR composite definition* 22 18 29 0.268

‘n’ without EMR prevalent diabetes 1,871 1,272 599

Incident Diabetes* (%)
 ICD-9 Code 19 15 28 0.321
 HbA1c ≥6.5% at least once 15 12 23 0.288
 HbA1c ≥6.5% two or more times 10 7 15 0.242
 HbA1c ≥6.5% two or more times within a year 6 5 10 0.219
 EMR composite definition 17 14 24 0.266

‘n’ without Chart Review prevalent diabetes 1,860 1,265 595

Incident Diabetes* (%)

 Chart adjudication 13 11 19 0.238

Presence of Diabetes** (%)

 ICD-10 Code 32 26 41 0.308

 Chart adjudication 31 24 41 0.338
*

EMR composite definition described in Table 1

**

Diabetes presence is based on chart review with a last date of October 2017 and ICD-10 codes from October 2015 to February 2018; limited to those alive as of October 2016 (n=1,118 PWH and 635 HIV-negative)

Abbreviations: VACS, Veterans Aging Cohort Study; HIV, human immunodeficiency virus; PWH, persons with HIV; HCV, Hepatitis C Virus; EMR, electronic medical record; ICD-9, International Classification of Diseases, Ninth Revision; HbA1c, hemoglobin A1c; ICD-10, International Classification of Diseases, Tenth Revision